AzTrials
AzTrials

Subacromial Impingement SyndromeNCT07228455

The Effect of Humeral Head Depressor Strengthening in Individuals With Subacromial Impingement Syndrome

A study testing Humeral Head Depressor Exercises and Standard physical therapy in people with Subacromial Impingement Syndrome, run by Near East University, Turkey at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Subacromial impingement syndrome is a common musculoskeletal disorder. Therefore, to improve the shoulder biomechanics affected by the syndrome, an intervention group was compared with a control group. The exercise program applied to the intervention group is expected to improve the function of the shoulder complex. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Subacromial Impingement Syndrome
What is being tested?
Humeral Head Depressor Exercises and Standard physical therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteCyprus
Study dates
3 Jul 2023to 3 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Volunteers who complained of shoulder pain for more than a month,
  • Who had limitation in passive movement compared to the other side shoulder,
  • Who had Neer impingement test, Hawkins test, Jobe supraspinatus test, and -
  • Who were able to com-municate were included in the study

Who cannot join

  • Having any neurological condition affecting the upper extremity,
  • Having neuro-logical findings related to cervical disc herniation,
  • Having a full-thickness rupture of one of the rotator cuff tendons,
  • Having calcific tendonitis,
  • Having undergone previous shoulder surgery,
  • Physical therapy-rehabilitation for the shoulder with the same complaints in the last 6 months,
  • Receiving corticosteroid injection were excluded from the study

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Near East University Hospital

    Nicosia

Other trials in Cyprus

About this study

Subacromial impingement syndrome is a common musculoskeletal disorder. Therefore, to improve the shoulder biomechanics affected by the syndrome, an intervention group was compared with a control group. The exercise program applied to the intervention group is expected to improve the function of the shoulder complex.

Read the detailed description

Subacromial Impingement Syndrome (SIS) is one of the most common musculoskeletal problems in the shoulder joint. This study aimed to investigate the effectiveness of a rehabilitation program targeting humeral head depressor muscles on symptoms in individuals with SIS.Participants were randomly divided into study and control groups.Volunteers who complained of shoulder pain for more than a month, who had limitation in passive movement compared to the other side shoulder, who had Neer impingement test, Hawkins test, Jobe supraspinatus test, and who were able to com-municate were included in the study. Individuals 1) Having any neurological condition affecting the upper extremity, 2) having neurological findings related to cervical disc herniation, 3) having a full-thickness rupture of one of the rotator cuff tendons, 4) having calcific tendonitis, 5) having undergone previous shoulder surgery and 6) Physical therapy-rehabilitation for the shoulder with the same complaints in the last 6 months, or 7) receiving corticosteroid injection were excluded from the study. While the control group received standard physical therapy and rehabilitation, the study group underwent a progressive resistance exercise program to strengthen the humeral head depressors and peri-articular muscles, including the rotator cuff. Acromio-humeral distance (AHD) and tendon thickness measurements were evaluated by ultrasonography, while pain intensity was measured through VAS and McGill Questionnaire, upper extremity disability through DASH-T, and kinesiophobia through Fear Avoidance Beliefs Questionnaire, respectively.

Being tested
Humeral Head Depressor Exercises, Standard physical therapy
Medical subject headings
Shoulder Impingement Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Humeral Head Depressor ExercisesBehavioural

    The Intervention group underwent a progressive resistance exercise program to strengthen the humeral head depressors and peri-articular muscles, including the rotator cuff. Exercises were performed 3 times per week for 6 weeks, each session lasting approximately 1 hour

  • Standard physical therapyBehavioural

    Participants in this group received standard physical therapy and rehabilitation as usually applied in routine care. Exercises were performed 3 times per week for 6 weeks, each session lasting approximately 1 hour. Outcomes were measured at the same time points as the intervention group.

Study groups in NCT07228455
Study groupRoleWhat they receive
The Intervention GroupExperimentalThe Intervention group underwent a progressive resistance exercise program to strengthen the humeral head depressors and peri-articular muscles, including the rotator cuff. The exercises were performed 3 times per week for 6 weeks, with each session lasting approximately 1 hour
Receives: Behavioral: Humeral Head Depressor Exercises
The Control GroupActive comparatorParticipants in the control group received standard physical therapy and rehabilitation as usually applied in routine care. Sessions were performed 3 times per week for 6 weeks, each lasting approximately 1 hour.
Receives: Behavioral: Standard physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acromio-humeral Distance (Ultrasonography, USG)

    Measured: Baseline and 6 weeks

Secondary outcomes (6)
  1. Tendon Thickness Measurment

    Supraspinatus Tendon, Infraspinatus Tendon, subscapularis Tendon, Teres Minor Tendon, Long Head Biceps Tendon, Rotator Cuff group Tendons General Thicknesses were evaluated in all planes, by USG using a GE LogiqP6 Pro device and a linear transducer. Imaging was performed using standard shoulder sections while the patients were in a sitting position

    Measured: Baseline and 6 week

  2. Pain (Visual Analog Scale, VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Measured: Baseline and 6 weeks

  3. Pain (McGill Pain Questionnaire-Pain Rating Index)

    Pain will be assessed using the McGill Pain Questionnaire, specifically the Pain Rating Index (PRI). The total score ranges from 0 to 78, with higher scores indicating more severe pain.

    Measured: Baseline and 6 weeks

  4. Kinesiophobia (Fear Avoidance Beliefs Questionnaire - FABQ, Physical Activity subscale)

    Kinesiophobia will be assessed using the Fear Avoidance Beliefs Questionnaire (FABQ) - Physical Activity subscale (items 2-5). Score range: 0 to 24 (higher scores indicate greater fear-avoidance beliefs related to physical activity).

    Time Frame: Baseline and 6 weeks.

    Measured: Baseline and 6 weeks

  5. Kinesiophobia (Fear Avoidance Beliefs Questionnaire - FABQ, Work subscale)

    Kinesiophobia will also be assessed using the FABQ - Work subscale (items 6, 7, 9-12, 15). Score range: 0 to 42 (higher scores indicate greater fear-avoidance beliefs related to work).

    Measured: Baseline and 6 weeks.

  6. Upper Extremity Disability Through (DASH-T)

    Measured: Baseline and 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2025
  2. Study start3 Jul 2023
  3. Primary completion3 Jul 2024
  4. Study completion3 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were quasi-randomly and sequentially assigned to either an intervention group receiving humeral head depressor exercises or a control group receiving routine exercise therapy. Each group followed their respective program for the duration of the study.
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07228455
Sponsor's protocol ID
2023/115-1751
Status last verified
Nov 2025
First submitted
29 Sep 2025
Last updated
14 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The individual participant data from this study will not be shared.

Publications

  • Kurtaran U, Yerlikaya T, Yenen B, Ozgul A. The Effect of Humeral Head Depressor Strengthening on Individuals with Subacromial Impingement Syndrome. Medicina (Kaunas). 2025 Nov 19;61(11):2061. doi: 10.3390/medicina61112061.

    PubMed 41303896

Questions about this trial

What is this clinical trial studying?

A study testing Humeral Head Depressor Exercises and Standard physical therapy in people with Subacromial Impingement Syndrome, run by Near East University, Turkey at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acromio-humeral Distance (Ultrasonography, USG) (time frame: Baseline and 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07228455, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in